[Patients evaluate osteoporosis therapy. Once a week is preferred].
D019386:Alendronate / Q000008:administration & dosage*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic
D019386:Alendronate